These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 39156790)

  • 1. Knockdown of fibrillin-1 suppresses retina-blood barrier dysfunction by inhibiting vascular endothelial apoptosis under diabetic conditions.
    Zhang Y; Liu XJ; Zhai XR; Yao Y; Shao B; Zhen YH; Zhang X; Xiao Z; Wang LF; Zhang ML; Chen ZM
    Int J Ophthalmol; 2024; 17(8):1403-1410. PubMed ID: 39156790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Α-Melanocyte-Stimulating Hormone Protects Early Diabetic Retina from Blood-Retinal Barrier Breakdown and Vascular Leakage via MC4R.
    Cai S; Yang Q; Hou M; Han Q; Zhang H; Wang J; Qi C; Bo Q; Ru Y; Yang W; Gu Z; Wei R; Cao Y; Li X; Zhang Y
    Cell Physiol Biochem; 2018; 45(2):505-522. PubMed ID: 29402864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteopontin-induced vascular hyperpermeability through tight junction disruption in diabetic retina.
    Someya H; Ito M; Nishio Y; Sato T; Harimoto K; Takeuchi M
    Exp Eye Res; 2022 Jul; 220():109094. PubMed ID: 35490836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genipin relieves diabetic retinopathy by down-regulation of advanced glycation end products via the mitochondrial metabolism related signaling pathway.
    Sun KX; Chen YY; Li Z; Zheng SJ; Wan WJ; Ji Y; Hu K
    World J Diabetes; 2023 Sep; 14(9):1349-1368. PubMed ID: 37771331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Qi-Ju-Di-Huang-Pill delays the progression of diabetic retinopathy.
    Zhao C; Ma G; Tao S; Wang M; Chen Z; Fang Y; Shi W
    J Ethnopharmacol; 2024 Apr; 323():117751. PubMed ID: 38216102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of total lignans from Fructus Arctii on Streptozotocin-induced diabetic retinopathy in Wistar rats.
    Zhang H; Gao Y; Zhang J; Wang K; Jin T; Wang H; Ruan K; Wu F; Xu Z
    J Ethnopharmacol; 2020 Jun; 255():112773. PubMed ID: 32199990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased lysyl oxidase level protects against development of retinal vascular lesions in diabetic retinopathy.
    Kim D; Mecham RP; Nguyen NH; Roy S
    Exp Eye Res; 2019 Jul; 184():221-226. PubMed ID: 31022398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C1q/TNF-related protein-9 attenuates retinal inflammation and protects blood-retinal barrier in db/db mice.
    Li W; Ma N; Liu MX; Ye BJ; Li YJ; Hu HY; Tang YH
    Eur J Pharmacol; 2019 Jun; 853():289-298. PubMed ID: 30978318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA HOTTIP improves diabetic retinopathy by regulating the p38-MAPK pathway.
    Sun Y; Liu YX
    Eur Rev Med Pharmacol Sci; 2018 May; 22(10):2941-2948. PubMed ID: 29863235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythropoietin protects the inner blood-retinal barrier by inhibiting microglia phagocytosis via Src/Akt/cofilin signalling in experimental diabetic retinopathy.
    Xie H; Zhang C; Liu D; Yang Q; Tang L; Wang T; Tian H; Lu L; Xu JY; Gao F; Wang J; Jin C; Li W; Xu G; Xu GT; Zhang J
    Diabetologia; 2021 Jan; 64(1):211-225. PubMed ID: 33104828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGR5 receptor activation attenuates diabetic retinopathy through suppression of RhoA/ROCK signaling.
    Zhu L; Wang W; Xie TH; Zou J; Nie X; Wang X; Zhang MY; Wang ZY; Gu S; Zhuang M; Tan J; Shen C; Dai Y; Yang X; Yao Y; Wei TT
    FASEB J; 2020 Mar; 34(3):4189-4203. PubMed ID: 31957105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The emerging roles of clusterin on reduction of both blood retina barrier breakdown and neural retina damage in diabetic retinopathy.
    Zhang C; Nie J; Feng L; Luo W; Yao J; Wang F; Wang H
    Discov Med; 2016 Apr; 21(116):227-37. PubMed ID: 27232509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genipin ameliorates diabetic retinopathy via the HIF-1α and AGEs-RAGE pathways.
    Sun K; Chen Y; Zheng S; Wan W; Hu K
    Phytomedicine; 2024 Jul; 129():155596. PubMed ID: 38626646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endomucin restores depleted endothelial glycocalyx in the retinas of streptozotocin-induced diabetic rats.
    Niu T; Zhao M; Jiang Y; Xing X; Shi X; Cheng L; Jin H; Liu K
    FASEB J; 2019 Dec; 33(12):13346-13357. PubMed ID: 31545913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PHD2 attenuates high-glucose-induced blood retinal barrier breakdown in human retinal microvascular endothelial cells by regulating the Hif-1α/VEGF pathway.
    Li J; Lu X; Wei L; Ye D; Lin J; Tang X; Cui K; Yu S; Xu Y; Liang X
    Inflamm Res; 2022 Jan; 71(1):69-79. PubMed ID: 34773469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythropoietin maintains VE-cadherin expression and barrier function in experimental diabetic retinopathy via inhibiting VEGF/VEGFR2/Src signaling pathway.
    Liu D; Xu H; Zhang C; Xie H; Yang Q; Li W; Tian H; Lu L; Xu JY; Xu G; Liu K; Sun X; Xu GT; Zhang J
    Life Sci; 2020 Oct; 259():118273. PubMed ID: 32800831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NADH-Cytochrome B5 reductase 2 suppresses retinal vascular dysfunction through regulation of vascular endothelial growth factor A in diabetic retinopathy.
    Chen J; Sun Y; Chen L; Zhou Y
    Exp Eye Res; 2022 Sep; 222():109186. PubMed ID: 35820466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The protective effect of human umbilical cord mesenchymal stem cells-induced neural stem cells in the vitreous on the blood-retinal barrier in diabetic rats].
    Dong M; Zhang W; Chen S; Wang JM; Duan HT; Kong JH; Wang YX; Bi X; Song J
    Zhonghua Yan Ke Za Zhi; 2017 Jan; 53(1):53-58. PubMed ID: 28162200
    [No Abstract]   [Full Text] [Related]  

  • 19. Vascular endothelial growth factor-A
    Ved N; Hulse RP; Bestall SM; Donaldson LF; Bainbridge JW; Bates DO
    Clin Sci (Lond); 2017 Jun; 131(12):1225-1243. PubMed ID: 28341661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of experimental diabetic vascular leakage by delivery of angiostatin with a recombinant adeno-associated virus vector.
    Shyong MP; Lee FL; Kuo PC; Wu AC; Cheng HC; Chen SL; Tung TH; Tsao YP
    Mol Vis; 2007 Jan; 13():133-41. PubMed ID: 17293777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.